Calcium D-Glucarate for Detoxification

Research suggests that calcium D-glucarate may support the body's detoxification processes primarily by inhibiting beta-glucuronidase, an enzyme involved in Phase II liver detoxification, with two reviews from the early 2000s indicating that this mechanism could play a role in carcinogen clearance, estrogen metabolism, and potentially reducing risk for hormone-dependent cancers. A 1997 animal study provides some mechanistic support, demonstrating that the active metabolite D-glucaro-1,4-lactone is produced after oral administration and distributed to relevant tissues in rats, though animal findings do not always translate directly to humans. A 2025 case report describes apparent normalization of estrogen metabolite ratios in a single patient using calcium D-glucarate alongside other supplements, but a single case report cannot establish causation or rule out the effects of the co-interventions used. The existing evidence base consists largely of reviews, animal research, and a case report rather than controlled human clinical trials, which means the overall findings are directionally consistent but remain preliminary, and stronger evidence from randomized controlled trials in humans would be needed to draw firmer conclusions.